[1]
Villegas-Mejía, C.R., Villegas Jaramillo, M. and Villegas Jaramillo, P. 2020. Temozolomide as adjuvance in Glioblastoma, how long is enough? The experience of a cancer centre en Colombia. Acta Médica Colombiana. 45, 4 (May 2020). DOI:https://doi.org/10.36104/amc.2020.1325.